by Heather Galipeau
While celiac disease affects predominantly the small intestine, the contribution of the small intestinal microbiota has been largely understudied. New findings characterize the duodenal microbiota in patients with active celiac disease and explores its functional relevance.
by Heather Galipeau
Many studies have reported changes in gut microbiome composition in patients with inflammatory bowel disease, including ulcerative colitis, when compared with healthy individuals. While that clearly raises the question about the key role played by gut microbes in IBD pathogenesis, we have yet to pinpoint the causative microbes and their mechanisms.
by Heather Galipeau
Evidence over the past few years suggests that metabolites produced from microbes in the gut play a crucial role in maintaining gut health.
by Heather Galipeau
Genetic predisposition alone cannot fully explain the current rise of food sensitivities, like celiac disease. Scientists have characterized the bacterial enzyme elastase involved in driving immune activation and worsening reactions to gluten in genetically susceptible hosts.
by Heather Galipeau
The effects of the microbiota on immunity and metabolism have been well characterized, but the basic understanding of how microbes influence the overall structure and function of the intestinal barrier is not well understood.
by Heather Galipeau
According to a new study gut microbiota-dependent signals are critical contributors to a pre-leukemic state in mice that lack Tet2 expression.
by Heather Galipeau
A new study shows that a specific probiotic can help treat symptoms of depression in patients who suffer from irritable bowel syndrome (or IBS).
by Heather Galipeau
A new study published in Science by Bouziat and colleagues show that reovirus, which are mild or clinically silent viruses that infect humans frequently over the course of a lifetime, can break tolerance to dietary proteins and may constitute an environmental modifier for CeD development.
Canada Heather Galipeau is a Research Associate at McMaster University (Canada) where she is researching dietary and microbial interactions in celiac disease and inflammatory bowel disease. She obtained her PhD in 2015 from McMaster University in Elena Verdu’s lab, during
by Heather Galipeau
The Gairdner Foundation and the Farncombe Institute at McMaster University (Canada) held a joint symposium, “The Intestinal Microbiome: Beyond Associations and into the Clinic”.
